Reports Strong Revenue, Gross Margin, and Income Growth Details Exciting Progress on Contamination Prevention Category Creation MISSISSAUGA, Ontario–(BUSINESS WIRE)–Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 second quarter results for the period ended March 31, 2026, along with its recent achievements and … [Read more…]
– The disease remains a public health challenge with an estimated 50,000 to 90,000 new cases each year – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced a renewed five-year collaboration with the World Health Organization (WHO), committing funding, strategic support and product donations to accelerate progress toward eliminating visceral leishmaniasis (VL), also … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–#BofA–American Healthcare REIT, Inc. (NYSE: AHR; the “Company”) announced today the pricing of an underwritten public offering of 14,000,000 shares of its common stock, all of which are being offered in connection with the forward sale agreement described below. The aggregate gross proceeds to the Company from the offering, before deducting estimated offering … [Read more…]
Showcase Presentation at AUA 2026 Innovation Nexus Ignites Excitement Around a New Era in Stone Management SAN FRANCISCO–(BUSINESS WIRE)–Avvio Medical, a clinical-stage medical device company developing Microbubble SonoLithotripsy for the treatment of ureteral stones, reports today on its successful conference at the 2026 American Urological Association (AUA) Annual Meeting, held May 15-18 in Washington, DC. … [Read more…]
– Data demonstrate mRNA delivery, protein expression and activity in the airways of PCD patients – – Abstract selected for oral presentation at 2026 American Thoracic Society International Conference – MENLO PARK, Calif.–(BUSINESS WIRE)–ReCode Therapeutics, a clinical-stage genetic medicines company using lipid nanoparticle delivery to power the next wave of mRNA and gene correction therapeutics, … [Read more…]
Strategic acquisition strengthens InSphero’s global position as the market leader in predictive in vitro modeling and high-content imaging services SCHLIEREN, Switzerland & SAN DIEGO–(BUSINESS WIRE)–#Imaging–InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, today announced the acquisition of PhenoVista Biosciences, Inc., a premier provider of … [Read more…]
Vertex Pulmonary Embolectomy System demonstrated significant right heart recovery, low adverse event rates, and reproducible performance across high-severity PE patients MENLO PARK, Calif.–(BUSINESS WIRE)–#TFX—Jupiter Endovascular, Inc. today announced that the SPIRARE II pivotal trial evaluating the use of the company’s Vertex™ Pulmonary Embolectomy System in patients with acute, intermediate-risk pulmonary embolism (PE) met both of … [Read more…]
New worldwide benchmark coincides with the 25th anniversary of AHF’s first international programs in South Africa and Uganda as AHF approaches 40 years of service and advocacy LOS ANGELES–(BUSINESS WIRE)–#AHFcares—AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS organization, is proud to announce a historic new milestone: 3 million lives in care worldwide. The achievement reflects … [Read more…]
Consolidated net sales of TWYMEEG® in Japan for the first quarter of 2026 reached JPY 2.3 billion (€12.8 million 1), up 36% compared to the first quarter of 2025. Poxel generated revenue of €1.277 million for the first quarter of 2026. Consolidated net sales of TWYMEEG® in Japan for Sumitomo Pharma2 reached JPY 9.35 billion … [Read more…]
Supplemental BLA seeks to expand the ANKTIVA label to include patients with BCG-unresponsive NMIBC with papillary disease FDA noted in its filing communication that the supplemental BLA accepted for review was based on the additional scientific data ImmunityBio provided at the Agency’s request, detailing the overlapping features of papillary and CIS disease to determine adequate … [Read more…]
